Published in Cephalalgia on April 21, 2011
Power failure: why small sample size undermines the reliability of neuroscience. Nat Rev Neurosci (2013) 13.37
Genome-wide association analysis identifies susceptibility loci for migraine without aura. Nat Genet (2012) 1.64
Age-specific association of migraine with cryptogenic TIA and stroke: Population-based study. Neurology (2015) 1.42
Sensitivity to acute cerebral ischemic injury in migraineurs: A retrospective case-control study. Neurology (2015) 1.39
Migraine and stroke: "vascular" comorbidity. Front Neurol (2014) 0.87
Internal carotid artery dissection following chiropractic treatment in a pregnant woman with Systemic Lupus Erythematosus. Chiropr Man Therap (2012) 0.86
The Migraine-Stroke Connection. J Stroke (2016) 0.82
Migraine with aura: which patients are most at risk of stroke? Neurol Sci (2015) 0.79
Headache attributed to cranial or cervical vascular disorders. Curr Pain Headache Rep (2013) 0.75
Migraine is associated with an increased risk of cervicocephalic arterial dissection. Cephalalgia (2011) 0.75
Yoga intervention on blood NO in female migraineurs. Adv Biomed Res (2015) 0.75
Congenital hypoplasia of bilateral internal carotid artery with migraine-like headache with aura. Chin Med J (Engl) (2015) 0.75
Time-of-flight angiography: a viable alternative to contrast-enhanced MR angiography and fat-suppressed T1w images for the diagnosis of cervical artery dissection? Eur Radiol (2013) 0.75
Transient Horner's syndrome as sign of intrapetrous carotid dissection in a migrainous patient. Neurol Sci (2012) 0.75
Measuring inconsistency in meta-analyses. BMJ (2003) 128.20
Bias in meta-analysis detected by a simple, graphical test. BMJ (1997) 122.24
Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA (2000) 55.37
The International Classification of Headache Disorders: 2nd edition. Cephalalgia (2004) 49.94
Operating characteristics of a rank correlation test for publication bias. Biometrics (1994) 47.97
Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache Classification Committee of the International Headache Society. Cephalalgia (1988) 14.61
Migraine and risk of cardiovascular disease in women. JAMA (2006) 6.16
Migraine as a risk factor for subclinical brain lesions. JAMA (2004) 5.02
Migraine and cardiovascular disease: systematic review and meta-analysis. BMJ (2009) 4.98
Altered arterial function in migraine of recent onset. Neurology (2007) 4.25
A note on graphical presentation of estimated odds ratios from several clinical trials. Stat Med (1988) 3.91
Analysis of 1008 consecutive patients aged 15 to 49 with first-ever ischemic stroke: the Helsinki young stroke registry. Stroke (2009) 3.39
Migraine. Lancet (2004) 3.20
A systematic review of the risk factors for cervical artery dissection. Stroke (2005) 2.90
Migraine headache in middle age and late-life brain infarcts. JAMA (2009) 2.65
Migraine, vascular risk, and cardiovascular events in women: prospective cohort study. BMJ (2008) 2.48
Migraine mediates the influence of C677T MTHFR genotypes on ischemic stroke risk with a stroke-subtype effect. Stroke (2007) 2.02
The epidemiology, burden, and comorbidities of migraine. Neurol Clin (2009) 1.81
Head pain in non-traumatic carotid artery dissection: a series of 65 patients. Cephalalgia (1994) 1.67
Migraine with aura is a risk factor for cervical artery dissection: a case-control study. Cerebrovasc Dis (2010) 1.57
Headache, migraine, and structural brain lesions and function: population based Epidemiology of Vascular Ageing-MRI study. BMJ (2011) 1.51
The International classification of headache disorders, 2nd edn (ICDH-II). J Neurol Neurosurg Psychiatry (2004) 1.39
Migraine--a risk factor for dissection of cervical arteries. Headache (1989) 1.26
Pain as the only symptom of cervical artery dissection. J Neurol Neurosurg Psychiatry (2006) 1.24
The genetics of cervical artery dissection: a systematic review. Stroke (2009) 1.23
MTHFR 677C>T and ACE D/I polymorphisms in migraine: a systematic review and meta-analysis. Headache (2009) 1.22
Migraine as a systemic disorder. Neurology (2007) 1.18
Vascular risk factors and morphometric data in cervical artery dissection: a case-control study. J Neurol Neurosurg Psychiatry (2009) 1.16
Migraine and the risk of cervical artery dissection: a case-control study. Neurology (2002) 1.11
History of migraine and the risk of spontaneous cervical artery dissection. Cephalalgia (2005) 1.08
Adult cervicocerebral artery dissection: a single-center study of 301 Finnish patients. Eur J Neurol (2009) 0.82
Serum elastase activity is elevated in migraine. Ann Neurol (2000) 0.82
[Spontaneous carotid and vertebral arteries dissection in a multiethnic population]. Arq Neuropsiquiatr (2007) 0.79
Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med (2009) 39.97
Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet (2010) 11.25
Apixaban in patients with atrial fibrillation. N Engl J Med (2011) 9.97
Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med (2015) 9.58
Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA (2008) 8.32
Telmisartan to prevent recurrent stroke and cardiovascular events. N Engl J Med (2008) 7.25
Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial. Circulation (2011) 6.48
Migraine and risk of cardiovascular disease in women. JAMA (2006) 6.16
Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. N Engl J Med (2008) 6.08
Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med (2014) 5.44
NXY-059 for acute ischemic stroke. N Engl J Med (2006) 5.32
Measures of obesity and cardiovascular risk among men and women. J Am Coll Cardiol (2008) 5.28
Vitamins E and C in the prevention of prostate and total cancer in men: the Physicians' Health Study II randomized controlled trial. JAMA (2008) 5.13
Migraine and cardiovascular disease: systematic review and meta-analysis. BMJ (2009) 4.98
Cost of disorders of the brain in Europe 2010. Eur Neuropsychopharmacol (2011) 4.63
Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. N Engl J Med (2004) 4.39
OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program. Headache (2010) 4.37
Benzodiazepine use and risk of dementia: prospective population based study. BMJ (2012) 4.32
NXY-059 for the treatment of acute ischemic stroke. N Engl J Med (2007) 3.70
Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial. JAMA (2005) 3.54
Intracranial hemorrhage in atrial fibrillation patients during anticoagulation with warfarin or dabigatran: the RE-LY trial. Stroke (2012) 3.02
Gleason score and lethal prostate cancer: does 3 + 4 = 4 + 3? J Clin Oncol (2009) 2.94
Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF. Lancet Neurol (2012) 2.77
A prospective cohort study of cancer incidence following the diagnosis of Parkinson's disease. Cancer Epidemiol Biomarkers Prev (2007) 2.77
Frovatriptan for prophylactic treatment of cluster headache: lessons for future trial design. Headache (2010) 2.72
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J (2016) 2.70
Exceptional longevity in men: modifiable factors associated with survival and function to age 90 years. Arch Intern Med (2008) 2.67
Cardiovascular disease and subsequent kidney disease. Arch Intern Med (2007) 2.65
Migraine and risk of haemorrhagic stroke in women: prospective cohort study. BMJ (2010) 2.63
Prospective study of Trichomonas vaginalis infection and prostate cancer incidence and mortality: Physicians' Health Study. J Natl Cancer Inst (2009) 2.50
Migraine and risk of cardiovascular disease in men. Arch Intern Med (2007) 2.49
Migraine, vascular risk, and cardiovascular events in women: prospective cohort study. BMJ (2008) 2.48
Migraine frequency and risk of cardiovascular disease in women. Neurology (2009) 2.47
Responsiveness of efficacy endpoints in clinical trials with over the counter analgesics for headache. Cephalalgia (2012) 2.46
Risks for stroke, bleeding, and death in patients with atrial fibrillation receiving dabigatran or warfarin in relation to the CHADS2 score: a subgroup analysis of the RE-LY trial. Ann Intern Med (2011) 2.45
Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation. Europace (2015) 2.35
Inverse association between cancer and Alzheimer's disease: results from the Framingham Heart Study. BMJ (2012) 2.32
Association between body mass index and CKD in apparently healthy men. Am J Kidney Dis (2005) 2.30
Migraine and mortality: a systematic review and meta-analysis. Cephalalgia (2011) 2.18
Migraine and obesity: epidemiology, mechanisms, and implications. Headache (2009) 2.05
Complications of endotracheal intubation in the critically ill. Intensive Care Med (2008) 2.04
Obesity and recurrent vascular risk after a recent ischemic stroke. Stroke (2011) 2.04
Incidence of cardiovascular disease and cancer in advanced age: prospective cohort study. BMJ (2008) 2.01
Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial. Lancet Neurol (2012) 1.99
Genome-wide association study reveals three susceptibility loci for common migraine in the general population. Nat Genet (2011) 1.98
A prospective study of polyunsaturated fatty acid levels in blood and prostate cancer risk. Cancer Epidemiol Biomarkers Prev (2007) 1.94
Predicting functional outcome and survival after acute ischemic stroke. J Neurol (2002) 1.92
Waist-to-hip ratio, body mass index, and subsequent kidney disease and death. Am J Kidney Dis (2008) 1.92
A large prospective study of SEP15 genetic variation, interaction with plasma selenium levels, and prostate cancer risk and survival. Cancer Prev Res (Phila) (2010) 1.92
Geographic patterns in overall and specific cardiovascular disease incidence in apparently healthy men in the United States. Stroke (2007) 1.91
Outcome parameters for trials in atrial fibrillation: executive summary. Eur Heart J (2007) 1.90
Cholesterol and the risk of renal dysfunction in apparently healthy men. J Am Soc Nephrol (2003) 1.87
Cluster headache: clinical presentation, lifestyle features, and medical treatment. Headache (2006) 1.86
Physical activity and risk of stroke in women. Stroke (2010) 1.85
Interobserver agreement in the classification of stroke in the Women's Health Study. Stroke (2003) 1.81
Cryptogenic Stroke and underlying Atrial Fibrillation (CRYSTAL AF): design and rationale. Am Heart J (2010) 1.76
Safety and tolerability of NXY-059 for acute intracerebral hemorrhage: the CHANT Trial. Stroke (2007) 1.75
The safety of oral antifungal treatments for superficial dermatophytosis and onychomycosis: a meta-analysis. Am J Med (2007) 1.70
Dipyridamole for preventing recurrent ischemic stroke and other vascular events: a meta-analysis of individual patient data from randomized controlled trials. Stroke (2004) 1.69
Cluster headache: clinical features and therapeutic options. Dtsch Arztebl Int (2011) 1.69
Acute treatment of migraine with the selective 5-HT1F receptor agonist lasmiditan--a randomised proof-of-concept trial. Cephalalgia (2010) 1.67
Efficacy and tolerability of lasmiditan, an oral 5-HT(1F) receptor agonist, for the acute treatment of migraine: a phase 2 randomised, placebo-controlled, parallel-group, dose-ranging study. Lancet Neurol (2012) 1.67
Impact of resting heart rate on mortality, disability and cognitive decline in patients after ischaemic stroke. Eur Heart J (2012) 1.62
Age-related cataract in a randomized trial of vitamins E and C in men. Arch Ophthalmol (2010) 1.60
Chronic disease in men with newly diagnosed cancer: a nested case-control study. Am J Epidemiol (2010) 1.58
Migraine, weight gain and the risk of becoming overweight and obese: a prospective cohort study. Cephalalgia (2012) 1.55
Dose-dependent Association between Intermediate-acting Neuromuscular-blocking Agents and Postoperative Respiratory Complications. Anesthesiology (2015) 1.54
Influence of age on outcome from thrombolysis in acute stroke: a controlled comparison in patients from the Virtual International Stroke Trials Archive (VISTA). Stroke (2010) 1.53
Secondary stroke prevention with ximelagatran versus warfarin in patients with atrial fibrillation: pooled analysis of SPORTIF III and V clinical trials. Stroke (2007) 1.52
Prevention of medication overuse in patients with migraine. Pain (2010) 1.51
Dabigatran etexilate for stroke prevention in patients with atrial fibrillation: resolving uncertainties in routine practice. Thromb Haemost (2012) 1.51
Incidence and remaining lifetime risk of Parkinson disease in advanced age. Neurology (2009) 1.48
Assessment of functioning and disability after ischemic stroke. Stroke (2002) 1.48
Migraine and cognitive decline: a topical review. Headache (2013) 1.48
Use of propensity score technique to account for exposure-related covariates: an example and lesson. Med Care (2007) 1.44
A prospective study of trans-fatty acid levels in blood and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev (2008) 1.44
Factors predicting the probability of relapse after discontinuation of migraine preventive treatment with topiramate. Cephalalgia (2010) 1.43
Effects of vitamin E on stroke subtypes: meta-analysis of randomised controlled trials. BMJ (2010) 1.43
A 25-year prospective study of plasma adiponectin and leptin concentrations and prostate cancer risk and survival. Clin Chem (2009) 1.41
Interrelationships among the MTHFR 677C>T polymorphism, migraine, and cardiovascular disease. Neurology (2008) 1.41
Neurologic worsening during the acute phase of ischemic stroke. Arch Neurol (2005) 1.40
Development of a risk score for colorectal cancer in men. Am J Med (2007) 1.39
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Europace (2016) 1.39
Why should American headache and migraine patients still be treated with butalbital-containing medicine? Headache (2012) 1.38
The relative strength of C-reactive protein and lipid levels as determinants of ischemic stroke compared with coronary heart disease in women. J Am Coll Cardiol (2006) 1.36
Headache and emergency medicine: sharing a language for a common project. Intern Emerg Med (2008) 1.36
Dementia risk prediction in the population: are screening models accurate? Nat Rev Neurol (2010) 1.35
The Virtual International Stroke Trials Archive. Stroke (2007) 1.34
Circulating prediagnostic interleukin-6 and C-reactive protein and prostate cancer incidence and mortality. Int J Cancer (2009) 1.29
Migraine mutations increase stroke vulnerability by facilitating ischemic depolarizations. Circulation (2011) 1.28
Vascular risk factors, cardiovascular disease, and restless legs syndrome in women. Am J Med (2013) 1.28